
CGEM EPS Estimates
Cullinan Therapeutics, Inc.
$9.16
+$0.14(+1.61%)
39
Overall
60
Value
36
Tech
21
Quality
Market Cap
$594.35M
Volume
723.21K
52W Range
$8.23 - $23.19
Target Price
$35.91
CGEM EPS estimates: the consensus estimate for Cullinan Therapeutics, Inc.'s current fiscal year is -$3.01 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CGEM EPS Estimates
- EPS estimate, current quarter
- $-0.70
- EPS estimate, next quarter
- $-0.41
- EPS estimate, current year
- $-3.01
- EPS estimate, next year
- $-2.41
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.36 |
| 2023 | $-3.69 |
| 2022 | $2.46 |
| 2021 | $-1.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEM | $9.16 | +1.6% | 723.21K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cullinan Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW